Regulation of μ binding sites after chronic administration of antibodies directed against specific anti-opiate peptides
- 12 January 1998
- Vol. 19 (10) , 1703-1709
- https://doi.org/10.1016/s0196-9781(98)00121-1
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Melanocortins and opiate addictionLife Sciences, 1997
- Opioid and anti‐opioid peptidesFundamental & Clinical Pharmacology, 1995
- Characterization and Solubilization of the FMRFamide Receptor of SquidThe Biological Bulletin, 1994
- Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1)Peptides, 1992
- Spinal dynorphin A (1–17): Possible mediator of antianalgesic actionNeuropharmacology, 1990
- Chronic morphine increases μ-opiate receptor binding in rat brain: a quantitative autoradiographic studyBrain Research, 1989
- Effect of prolyl-leucyl-glycinamide and α-melanocyte-stimulating hormone on levorphanol-induced analgesia, tolerance and dependenceLife Sciences, 1984
- Dynorphin1–8 and dynorphin1–9 are ligands for the κ-subtype of opiate receptorNature, 1982
- Specific receptor for the opioid peptide dynorphin: structure--activity relationships.Proceedings of the National Academy of Sciences, 1981
- Dynorphin: A possible modulatory peptide on morphine or β-endorphin analgesia in mouseEuropean Journal of Pharmacology, 1981